FDA inspection
Teva Pharmaceutical Industries Ltd.: FDA inspection ending Jul 18, 2019
FDA inspection 1102103 · No Action Indicated (NAI) · Jerusalem
Key facts
| Inspection ID | 1102103 |
|---|---|
| Firm | Teva Pharmaceutical Industries Ltd. |
| FEI number | 3003414719 |
| Address | 2, Hamarpeh Street |
| City | Jerusalem |
| Country | Israel |
| Fiscal year | 2019 |
| Inspection end date | Jul 18, 2019 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data